Withdrawal Notice

This paper was originally published in Aging Advance Online Publications on November 29, 2020.

In compliance with Aging's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Aging internal or any external indexes or archives.

WITHDRAWN: Exosomes derived from BDNF-expressing 293T attenuate ischemic retinal injury in vitro and in vivo

class="figure-viewer-img"

Figure 1. Characterization of 293T-Exo derived from BDNF-expressing 293T cells. (A) Diameter distribution of 293T-Exo determined by nanoparticle tracking analysis (NTA). (B) Representative image of 293T-Exo photographed by transmission electron microscopy (TEM). Scale bard = 100 nm. (C) Protein expressions of exosome surface markers, CD9, CD63, CD81, and HSP70α in 293T-Exo and 293T-Exo-conditioned medium (293T-CM), as measured using western blots.